Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Inari Medical, Inc. - Common Stock (NQ: NARI )

79.30 -0.15 (-0.19%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Inari Medical, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
INARI MEDICAL, INC. (NASDAQ: NARI) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Inari Medical, Inc.
From Bernstein Liebhard LLP
Via GlobeNewswire
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Inari Medical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – NARI
From Rosen Law Firm
Via Business Wire
Grant & Eisenhofer Files Class Action Lawsuit Against Inari Medical, Inc. on Behalf of Institutional Investor
From Grant & Eisenhofer P.A.
Via Business Wire
What 8 Analyst Ratings Have To Say About Inari Medical
Via Benzinga
Forecasting The Future: 7 Analyst Projections For Inari Medical
Via Benzinga
Lowey Dannenberg, P.C. is Investigating Inari Medical Inc. (“Inari” or the “Company”) (NASDAQ:NARI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm
From Lowey Dannenberg, P.C.
Via GlobeNewswire
Inari Medical to Participate in the 2024 Bank of America Securities Healthcare Conference
From Inari Medical, Inc.
Via GlobeNewswire
Lowey Dannenberg, P.C. is Investigating Inari Medical Inc. (“Inari” or the “Company”) (NASDAQ:NARI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm
From Lowey Dannenberg, P.C.
Via GlobeNewswire
Why AMD Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Powell Industries Posts Upbeat Results, Joins A10 Networks, Garmin, DuPont And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Why Pinterest Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket
Via Benzinga
NARI Stock Earnings: Inari Medical Misses EPS, Beats Revenue for Q1 2024
NARI stock results show that Inari Medical missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Inari Medical Reports First Quarter 2024 Financial Results
From Inari Medical, Inc.
Via GlobeNewswire
Lowey Dannenberg, P.C. is Investigating Inari Medical Inc. (“Inari” or the “Company”) (NASDAQ:NARI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm
From Lowey Dannenberg, P.C.
Via GlobeNewswire
Lowey Dannenberg, P.C. is Investigating Inari Medical Inc. (“Inari” or the “Company”) (NASDAQ:NARI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm
From Lowey Dannenberg, P.C.
Via GlobeNewswire
Inari Medical to Announce First Quarter 2024 Financial Results
From Inari Medical, Inc.
Via GlobeNewswire
Lowey Dannenberg, P.C. is Investigating Inari Medical Inc. (“Inari” or the “Company”) (NASDAQ:NARI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm
From Lowey Dannenberg, P.C.
Via GlobeNewswire
Inari Medical Announces the Release of 2023 Ethos and Sustainability Report
From Inari Medical, Inc.
Via GlobeNewswire
Lowey Dannenberg, P.C. is Investigating Inari Medical Inc. (“Inari” or the “Company”) (NASDAQ:NARI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm
From Lowey Dannenberg, P.C.
Via GlobeNewswire
Inari Medical Strengthens Senior Leadership Team with Addition of Two Executives
From Inari Medical, Inc.
Via GlobeNewswire
Market Cap Game Show: Andy Cross vs. Bill Mann
Join the "Rule Breaker Investing" fun. 
Via The Motley Fool
INARI MEDICAL (NASDAQ: NARI): Kaplan Fox &amp; Kilsheimer LLP Continues its Investigation of Inari Medical following Inari Medicals Disclosure of a DOJ Investigation related to Anti-Kickback laws
NEW YORK, NY - (NewMediaWire) - March 20, 2024 - Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Inari Medical, Inc. (“Inari Medical” or the “Company”)... 
Via TheNewswire.com
Topics Regulatory Compliance
Exposures Legal Regulatory
INARI MEDICAL (NASDAQ: NARI): Kaplan Fox & Kilsheimer LLP Continues its Investigation of Inari Medical following Inari Medicals Disclosure of a DOJ Investigation related to Anti-Kickback laws
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
INARI MEDICAL (NASDAQ: NARI) Investigated by Kaplan Fox & Kilsheimer LLP for Potential Securities Law Violations following Inari Medicals receipt of a Civil Investigative Demand from the DOJ
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
INARI MEDICAL (NASDAQ: NARI) Investigated by Kaplan Fox &amp; Kilsheimer LLP for Potential Securities Law Violations following Inari Medicals receipt of a Civil Investigative Demand from the DOJ
NEW YORK, NY - (NewMediaWire) - March 19, 2024 - Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Inari Medical, Inc. (“Inari Medical” or the “Company”)... 
Via TheNewswire.com
Topics Regulatory Compliance
Exposures Legal Regulatory
INARI MEDICAL (NASDAQ: NARI): Inari Medical Investigated for Potential Securities Law Violations - Investors of Inari Medical are Encouraged to Contact Kaplan Fox & Kilsheimer LLP
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
INARI MEDICAL (NASDAQ: NARI): Inari Medical Investigated for Potential Securities Law Violations - Investors of Inari Medical are Encouraged to Contact Kaplan Fox &amp; Kilsheimer LLP
NEW YORK, NY - (NewMediaWire) - March 18, 2024 - Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Inari Medical, Inc. (“Inari Medical” or the “Company”)... 
Via TheNewswire.com
Topics Regulatory Compliance
Exposures Legal Regulatory
INARI MEDICAL (NASDAQ: NARI): Inari Medical has Received a Civil Investigative Demand from the U.S. Department of Justice - Investors of Inari Medical are Encouraged to Contact Kaplan Fox & Kilsheimer LLP
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
INARI MEDICAL (NASDAQ: NARI): Inari Medical has Received a Civil Investigative Demand from the U.S. Department of Justice - Investors of Inari Medical are Encouraged to Contact Kaplan Fox &amp; Kilsheimer LLP
NEW YORK, NY - (NewMediaWire) - March 17, 2024 - Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Inari Medical, Inc. (“Inari Medical” or the “Company”)... 
Via TheNewswire.com
Topics Regulatory Compliance
Exposures Legal Regulatory
INARI MEDICAL (NASDAQ: NARI): Kaplan Fox & Kilsheimer LLP Continues its Investigation of Inari Medical Following Inari Medical's Disclosure of a DOJ Investigation Related to Anti-Kickback Laws
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.